Early on in the pandemic, many of us hoped that India would help vaccinate the world. India’s pharmaceutical sector, dominated by companies capable of churning out generic medicines in vast quantities, looked like the obvious location for vaccine production at the scale needed to inoculate the developing world.
That hasn’t worked out, partly because the Indian government restricted vaccine exports after the Delta variant emerged here — but also because of the unexpected and early success of the mRNA-based shots from Moderna Inc. and Pfizer Inc. These came on the market early and set high standards for efficacy against the original variant of the virus. But they were remarkably ill-suited for production and distribution in the emerging world. They need to be stored at untenably low temperatures, and their novel and unfamiliar production process isn’t easy to replicate.
"world" - Google News
January 11, 2022 at 06:00AM
https://ift.tt/3qdjNiX
To Vaccinate World Against Covid-19, We Need More Than mRNA Shots - Bloomberg
"world" - Google News
https://ift.tt/3d80zBJ
https://ift.tt/2WkdbyX
Bagikan Berita Ini
0 Response to "To Vaccinate World Against Covid-19, We Need More Than mRNA Shots - Bloomberg"
Post a Comment